Search
for
Sort by
Research 181–210 of 293
- Dermatologic Adverse Events from Cancer Treatments
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Controlling Hair Loss by Regulating Apoptosis in Hair Follicles: A Comprehensive Overview
- Biomolecules of Fermented Tropical Fruits and Fermenting Microbes as Regulators of Human Hair Loss, Hair Quality, and Scalp Microbiota
- Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy
- Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study
- The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial
- Effects of Curcumin and Its Different Formulations in Preclinical and Clinical Studies of Peripheral Neuropathic and Postoperative Pain: A Comprehensive Review
- S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma
- Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?
- Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment
- Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis
- Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
- Determination of finasteride, indapamide and tiemonium methyl sulphate using surface plasmon resonance band of silver nanoparticles
- A Nonrandomized Clinical Trial Investigating Keratinocyte Growth Factor‐Hair Serum for the Prevention of Chemotherapy‐Induced Alopecia
- Sub-acute toxicity of standardized aqueous extract of Siddha herb Karisalankanni - Eclipta alba (L.) Hassk
- Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials
- Exploring the Systematic Anticancer Mechanism in Selected Medicinal Plants: A Review
- Cytoprotective role of human dental pulp stem cell-conditioned medium in chemotherapy-induced alopecia
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- Chemotherapy‐induced alopecia: an exploratory questionnaire‐based study from Israel comparing knowledge, attitudes, and management practices among dermatologists and oncologists
- Quality of Life in Slovak Breast Cancer Survivors: A Cross-Sectional Study Using EORTC QLQ-C30 and BR23
- Food Bioactive Compounds and Emerging Techniques for Their Extraction: Polyphenols as a Case Study
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails